Login / Signup

Contingency management for smoking cessation among individuals with type 2 diabetes: protocol for a multi-center randomized controlled feasibility trial.

Sydney A MartinezSamantha L QuaifeAfsheen HasanKathryn A McMillanLaura A BeebeFiona Muirhead
Published in: Pilot and feasibility studies (2020)
This randomized controlled feasibility trial has been registered at ClinicalTrials.gov with an ID NCT03527667 on May 4, 2018.
Keyphrases
  • phase iii
  • smoking cessation
  • phase ii
  • open label
  • double blind
  • clinical trial
  • placebo controlled
  • study protocol
  • replacement therapy
  • randomized controlled trial